• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一针接种的 COVID-19 亚单位疫苗引发强烈的免疫应答。

Single-injection COVID-19 subunit vaccine elicits potent immune responses.

机构信息

Key Laboratory of Functional Polymer Materials and State Key Laboratory of Medicinal Chemical Biology, Institute of Polymer Chemistry, College of Chemistry, Nankai University, Tianjin 300071, China.

School of Chemistry, Tiangong University, Tianjin 300387, China.

出版信息

Acta Biomater. 2022 Oct 1;151:491-500. doi: 10.1016/j.actbio.2022.08.006. Epub 2022 Aug 7.

DOI:10.1016/j.actbio.2022.08.006
PMID:35948176
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9357281/
Abstract

Current vaccination schedules, including COVID-19 vaccines, require multiple doses to be administered. Single injection vaccines eliciting equivalent immune response are highly desirable. Unfortunately because unconventional release kinetics are difficult to achieve it still remains a huge challenge. Herein a single-injection COVID-19 vaccine was designed using a highly programmable release system based on dynamic layer-by-layer (LBL) films. The antigen, S1 subunit of SARS-CoV-2 spike protein, was loaded in CaCO microspheres, which were further coated with tannic acid (TA)/polyethylene glycol (PEG) LBL films. The single-injection vaccine was obtained by mixing the microspheres coated with different thickness of TA/PEG films. Because of the unique constant-rate erosion behavior of the TA/PEG coatings, this system allows for distinct multiple pulsatile release of antigen, closely mimicking the release profile of antigen in conventional multiple dose vaccines. Immunization with the single injection vaccine induces potent and persistent S1-specific humoral and cellular immune responses in mice. The sera from the vaccinated animal exhibit robust in vitro viral neutralization ability. More importantly, the immune response and viral inhibition induced by the single injection vaccine are as strong as that induced by the corresponding multiple dose vaccine, because they share the same antigen release profile. STATEMENT OF SIGNIFICANCE: Vaccines are the most powerful and cost-effective weapons against infectious diseases such as COVID-19. However, current vaccination schedules, including the COVID-19 vaccines, require multiple doses to be administered. Herein a single-injection COVID-19 vaccine is designed using a highly programmable release system. This vaccine releases antigens in a pulsatile manner, closely mimicking the release pattern of antigens in conventional multiple dose vaccines. As a result, one single injection of the new vaccine induces an immune response and viral inhibition similar to that induced by the corresponding multiple-dose vaccine approach.

摘要

目前的疫苗接种计划,包括 COVID-19 疫苗,需要多次接种。人们非常希望能够有一种只需要注射一次就能产生等效免疫反应的疫苗。不幸的是,由于非常规的释放动力学难以实现,这仍然是一个巨大的挑战。在此,我们设计了一种基于高度可编程的动态层层(LBL)膜释放系统的单次注射 COVID-19 疫苗。抗原,SARS-CoV-2 刺突蛋白的 S1 亚单位,被加载到碳酸钙微球中,然后用单宁酸(TA)/聚乙二醇(PEG)LBL 膜进一步包裹。通过混合涂覆不同厚度 TA/PEG 膜的微球获得了单次注射疫苗。由于 TA/PEG 涂层具有独特的恒速侵蚀行为,该系统允许抗原进行明显的多次脉冲释放,这种释放模式与传统多剂量疫苗中的抗原释放模式非常相似。在小鼠中进行单次注射疫苗免疫可诱导强烈和持久的 S1 特异性体液和细胞免疫反应。来自接种动物的血清在体外具有强大的病毒中和能力。更重要的是,单次注射疫苗诱导的免疫反应和病毒抑制与相应的多剂量疫苗一样强烈,因为它们具有相同的抗原释放模式。

意义声明

疫苗是对抗 COVID-19 等传染病最强大和最具成本效益的武器。然而,目前的疫苗接种计划,包括 COVID-19 疫苗,需要多次接种。在此,我们设计了一种基于高度可编程的释放系统的单次注射 COVID-19 疫苗。这种疫苗以脉冲方式释放抗原,这种释放模式与传统多剂量疫苗中的抗原释放模式非常相似。因此,单次注射新疫苗可诱导与相应多剂量疫苗接种方案相似的免疫反应和病毒抑制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480e/9357281/2135092005c9/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480e/9357281/0109dd697af1/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480e/9357281/c55d0f198083/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480e/9357281/10f559718585/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480e/9357281/72fafd4c86af/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480e/9357281/a5ee832a8117/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480e/9357281/fdaf724f893a/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480e/9357281/1de31e8e1179/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480e/9357281/a804bda932af/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480e/9357281/2135092005c9/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480e/9357281/0109dd697af1/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480e/9357281/c55d0f198083/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480e/9357281/10f559718585/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480e/9357281/72fafd4c86af/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480e/9357281/a5ee832a8117/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480e/9357281/fdaf724f893a/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480e/9357281/1de31e8e1179/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480e/9357281/a804bda932af/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480e/9357281/2135092005c9/gr8_lrg.jpg

相似文献

1
Single-injection COVID-19 subunit vaccine elicits potent immune responses.一针接种的 COVID-19 亚单位疫苗引发强烈的免疫应答。
Acta Biomater. 2022 Oct 1;151:491-500. doi: 10.1016/j.actbio.2022.08.006. Epub 2022 Aug 7.
2
Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.微针阵列递呈的重组冠状病毒疫苗:免疫原性和快速转化开发。
EBioMedicine. 2020 May;55:102743. doi: 10.1016/j.ebiom.2020.102743. Epub 2020 Apr 2.
3
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.在真实环境中评估灭活 COVID-19 疫苗诱导的 SARS-CoV-2 特异性体液和细胞免疫应答的特征。
Front Immunol. 2021 Dec 22;12:802858. doi: 10.3389/fimmu.2021.802858. eCollection 2021.
4
A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity.一种双抗原自扩增 RNA SARS-CoV-2 疫苗可诱导强烈的体液和细胞免疫应答,并通过 T 细胞介导的免疫来预防 SARS-CoV-2 变体。
Mol Ther. 2022 Sep 7;30(9):2968-2983. doi: 10.1016/j.ymthe.2022.04.014. Epub 2022 Apr 20.
5
Single-injection subunit vaccine for rabies prevention using lentinan as adjuvant.利用香菇多糖作为佐剂的狂犬病预防单剂亚单位疫苗。
Int J Biol Macromol. 2024 Jan;254(Pt 3):128118. doi: 10.1016/j.ijbiomac.2023.128118. Epub 2023 Nov 15.
6
First computational design using lambda-superstrings and in vivo validation of SARS-CoV-2 vaccine.首次使用λ-超弦进行的计算设计及SARS-CoV-2疫苗的体内验证。
Sci Rep. 2022 Apr 19;12(1):6410. doi: 10.1038/s41598-022-09615-w.
7
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.全面描述了针对 SARS-CoV-2 刺突蛋白的抗体反应,发现了除轻度感染诱导的表位之外的其他疫苗诱导的表位。
Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490.
8
RelCoVax®, a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice.瑞科巴韦®,一种针对 SARS-CoV-2 的两价抗原亚单位蛋白疫苗候选物,在小鼠中诱导强烈的免疫应答。
Vaccine. 2022 Jul 30;40(32):4522-4530. doi: 10.1016/j.vaccine.2022.06.026. Epub 2022 Jun 13.
9
A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2.一种新型 RBD 蛋白/肽疫苗可诱导广泛中和抗体,并保护小鼠和猕猴免受 SARS-CoV-2 感染。
Emerg Microbes Infect. 2022 Dec;11(1):2724-2734. doi: 10.1080/22221751.2022.2140608.
10
A Modular Biomaterial Scaffold-Based Vaccine Elicits Durable Adaptive Immunity to Subunit SARS-CoV-2 Antigens.基于模块化生物材料支架的疫苗可引发针对亚单位 SARS-CoV-2 抗原的持久适应性免疫。
Adv Healthc Mater. 2021 Nov;10(22):e2101370. doi: 10.1002/adhm.202101370. Epub 2021 Oct 4.

引用本文的文献

1
Single-Administration Self-Boosting Microneedle Patch for The Treatment of Obesity.用于治疗肥胖症的单次给药自增强微针贴剂。
Adv Ther (Weinh). 2024 Sep;7(9). doi: 10.1002/adtp.202400028. Epub 2024 May 21.
2
Unlocking insights: Navigating COVID-19 challenges and Emulating future pandemic Resilience strategies with strengthening natural immunity.解锁见解:应对新冠疫情挑战并通过增强自然免疫力效仿未来大流行的韧性策略。
Heliyon. 2024 Jul 17;10(15):e34691. doi: 10.1016/j.heliyon.2024.e34691. eCollection 2024 Aug 15.
3
Layer-by-Layer Nanoassemblies for Vaccination Purposes.

本文引用的文献

1
Subunit Nanovaccine with Potent Cellular and Mucosal Immunity for COVID-19.用于COVID-19的具有强大细胞免疫和黏膜免疫的亚单位纳米疫苗。
ACS Appl Bio Mater. 2020 Sep 21;3(9):5633-5638. doi: 10.1021/acsabm.0c00668. Epub 2020 Aug 26.
2
Hydrogel-Based Slow Release of a Receptor-Binding Domain Subunit Vaccine Elicits Neutralizing Antibody Responses Against SARS-CoV-2.基于水凝胶的受体结合域亚单位疫苗的缓慢释放可引发针对 SARS-CoV-2 的中和抗体应答。
Adv Mater. 2021 Dec;33(51):e2104362. doi: 10.1002/adma.202104362. Epub 2021 Oct 14.
3
Polymersomes as Stable Nanocarriers for a Highly Immunogenic and Durable SARS-CoV-2 Spike Protein Subunit Vaccine.
用于疫苗接种目的的逐层纳米组装体。
Pharmaceutics. 2023 May 10;15(5):1449. doi: 10.3390/pharmaceutics15051449.
聚合物囊泡作为一种稳定的纳米载体用于高免疫原性和持久性的 SARS-CoV-2 刺突蛋白亚单位疫苗。
ACS Nano. 2021 Oct 26;15(10):15754-15770. doi: 10.1021/acsnano.1c01243. Epub 2021 Oct 7.
4
A Modular Biomaterial Scaffold-Based Vaccine Elicits Durable Adaptive Immunity to Subunit SARS-CoV-2 Antigens.基于模块化生物材料支架的疫苗可引发针对亚单位 SARS-CoV-2 抗原的持久适应性免疫。
Adv Healthc Mater. 2021 Nov;10(22):e2101370. doi: 10.1002/adhm.202101370. Epub 2021 Oct 4.
5
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.佐剂 COVID-19 亚单位疫苗以诱导保护性免疫。
Nature. 2021 Jun;594(7862):253-258. doi: 10.1038/s41586-021-03530-2. Epub 2021 Apr 19.
6
Engineering a self-navigated MnARK nanovaccine for inducing potent protective immunity against novel coronavirus.构建一种用于诱导针对新型冠状病毒的强效保护性免疫的自导航MnARK纳米疫苗。
Nano Today. 2021 Jun;38:101139. doi: 10.1016/j.nantod.2021.101139. Epub 2021 Mar 19.
7
S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates.S-三聚体疫苗,一种 COVID-19 亚单位候选疫苗,可诱导非人灵长类动物产生保护性免疫。
Nat Commun. 2021 Mar 1;12(1):1346. doi: 10.1038/s41467-021-21634-1.
8
Engineered drug delivery devices to address Global Health challenges.用于应对全球健康挑战的工程药物输送装置。
J Control Release. 2021 Mar 10;331:503-514. doi: 10.1016/j.jconrel.2021.01.035. Epub 2021 Jan 28.
9
A highly programmable platform for sequential release of protein therapeutics.一种高度可编程的蛋白质治疗药物顺序释放平台。
J Mater Chem B. 2021 Feb 14;9(6):1616-1624. doi: 10.1039/d0tb02657c. Epub 2021 Jan 21.
10
Injectable Carrier for Zero-Order Release of Salmon Calcitonin.可注射载体零级释放鲑鱼降钙素。
ACS Biomater Sci Eng. 2020 Jan 13;6(1):485-493. doi: 10.1021/acsbiomaterials.9b01680. Epub 2019 Dec 13.